Patient Portal

Jeff M. Michalski, MD, MBA

Professor, Radiation Oncology
Vice Chairman, Radiation Oncology
Chief, Genitourinary Service

Specialty Areas

Radiation Oncology
Genitourinary Oncology
Sarcoma
Prostate Cancer
Intensity Modulated Radiation Therapy ( IMRT)
Pediatric Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
St. Louis Children's Hospital
Christian Hospital
Barnes-Jewish West County Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Radiation therapy, radiation oncology, pediatric oncology, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

  • Location(s)
  • Education
  • Publication & Research

Location(s)

Location(s)

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110

Floor: LL
Office Phone: 314-747-7236
Fax: 314-747-9557

Christian Hospital

11133 Dunn Road
St. Louis, MO 63136

Office Phone: 314-653-5255
Fax: 314-653-4283

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129

Education

Education

Instructor - Fellow: Washington University School of Medicine, Radiation Oncology Center, St. Louis, MO 1991
Resident: Radiation Oncology, Washington University School of Medicine, St. Louis, MO. 1990
Resident: Radiation Oncology, Columbia-Presbyterian Medical Center 1988
Medical Degree: Medical College Of Wisconsin 1986
B.S. Biochemistry: University of Wisconsin-Madison 1982

Publication & Research

Publication & Research

Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer.
Spratt DE, Michalski JM
Int J Radiat Oncol Biol Phys. 2019 Jul 15; 104(4)798-800. doi: 10.1016/j.ijrobp.2019.04.001.

PMID:
    31204661
    [PubMed - in process]
Related citations


Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients.
Michalski JM, Lyden ER, Lee AJ, Al-Kadhimi ZS, Maness LJ, Gundabolu K, Bhatt VR
Future Oncol. 2019 Jun; 15(17)1989-1995. doi: 10.2217/fon-2019-0001.

PMID:
    31170814
    [PubMed - in process]
Related citations


Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
Fischer-Valuck BW, Michalski JM, Mitra N, Christodouleas JP, DeWees TA, Kim E, Smith ZL, Andriole GL, Arora V, Bullock A, Carmona R, Figenshau RS, Grubb RL, Guzzo TJ, Knoche EM, Malkowicz SB, Mamtani R, Pachynski RK, Roth BJ, Zaghloul MS, Gay HA, Baumann BC
Cancer Med. 2019 Jul; 8(8)3698-3709. doi: 10.1002/cam4.2102.

PMID:
    31119885
    [PubMed - in process]
Related citations


Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM
Radiother Oncol. 2019 Jun; 13519-24. doi: 10.1016/j.radonc.2019.02.014.

PMID:
    31015166
    [PubMed - in process]
Related citations


Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial.
Rosenthal SA, Hu C, Sartor O, Gomella LG, Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Horwitz EM, Raben A, Peters CA, Feng FY, Shipley WU, Sandler HM
J Clin Oncol. 2019 May 10; 37(14)1159-1168. doi: 10.1200/JCO.18.02158.

PMID:
    30860948
    [PubMed - in process]
Related citations


Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
Bruner DW, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B
JAMA Oncol. 2019 Feb 14; doi: 10.1001/jamaoncol.2018.6752.

PMID:
    30763425
    [PubMed - as supplied by publisher]
Related citations


Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy.
Merfeld E, Gabani P, Spraker MB, Zoberi I, Kim H, Van Tine B, Chrisinger J, Michalski JM
Clin Oncol (R Coll Radiol). 2019 Apr; 31(4)232-241. doi: 10.1016/j.clon.2019.01.006.

PMID:
    30718086
    [PubMed - in process]
Related citations


NCTN Assessment on Current Applications of Radiomics in Oncology.
Nie K, Al-Hallaq H, Li XA, Benedict SH, Sohn JW, Moran JM, Fan Y, Huang M, Knopp MV, Michalski JM, Monroe J, Obcemea C, Tsien CI, Solberg T, Wu J, Xia P, Xiao Y, El Naqa I
Int J Radiat Oncol Biol Phys. 2019 Jun 1; 104(2)302-315. doi: 10.1016/j.ijrobp.2019.01.087.

PMID:
    30711529
    [PubMed - in process]
Related citations


A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
Fischer-Valuck BW, Michalski JM, Contreras JA, Brenneman R, Christodouleas JP, Abraham CD, Kim EH, Arora VK, Bullock AD, Carmona R, Figenshau RS, Grubb R 3rd, Knoche EM, Pachynski RK, Picus J, Roth BJ, Sargos P, Andriole GL, Gay HA, Baumann BC
Clin Transl Radiat Oncol. 2019 Feb; 1538-41. doi: 10.1016/j.ctro.2018.12.001.

PMID:
    30656221
    [PubMed]
Related citations


Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability.
Gabani P, Fischer-Valuck BW, Robinson CG, Wilson DB, Michalski JM
Pract Radiat Oncol. 2019 Jan; 9(1)5-8. doi: 10.1016/j.prro.2018.07.004.

PMID:
    30611463
    [PubMed - indexed for MEDLINE]
Related citations


Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM
Lancet Oncol. 2018 Nov; 19(11)1504-1515. doi: 10.1016/S1470-2045(18)30528-X.

PMID:
    30316827
    [PubMed - indexed for MEDLINE]
Related citations


Radiation Therapy for Prostate Cancer.
Gay HA, Michalski JM
Mo Med. 2018 Mar-Apr; 115(2)146-150.

PMID:
    30228707
    [PubMed - in process]
Related citations


Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.
Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M 3rd, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW
Adv Radiat Oncol. 2018 Jul-Sep; 3(3)405-411. doi: 10.1016/j.adro.2018.04.010.

PMID:
    30202809
    [PubMed]
Related citations


Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW, Baumann BC, Apicelli A, Rao YJ, Roach M, Daly M, Dans MC, White P, Contreras J, Henke L, Gay H, Michalski JM, Abraham C
Cancer Med. 2018 Sep; 7(9)4240-4250. doi: 10.1002/cam4.1655.

PMID:
    30120817
    [PubMed - in process]
Related citations


Responses of the Human Gut <i>Escherichia coli</i> Population to Pathogen and Antibiotic Disturbances.
Richter TKS, Michalski JM, Zanetti L, Tennant SM, Chen WH, Rasko DA
mSystems. 2018 Jul-Aug; 3(4)pii: e00047-18. doi: 10.1128/mSystems.00047-18.

PMID:
    30057943
    [PubMed]
Related citations


Intensity-modulated radiotherapy for prostate cancer.
Fischer-Valuck BW, Rao YJ, Michalski JM
Transl Androl Urol. 2018 Jun; 7(3)297-307. doi: 10.21037/tau.2017.12.16.

PMID:
    30050791
    [PubMed]
Related citations


Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA
Int J Radiat Oncol Biol Phys. 2018 Oct 1; 102(2)287-295. doi: 10.1016/j.ijrobp.2018.06.008.

PMID:
    29913254
    [PubMed - indexed for MEDLINE]
Related citations


Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.
Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H
JAMA Oncol. 2018 Sep 1; 4(9)1287-1288. doi: 10.1001/jamaoncol.2018.1258.

PMID:
    29852036
    [PubMed - in process]
Related citations


Practical Implications of Ferromagnetic Artifacts in Low-field MRI-guided Radiotherapy.
Green O, Henke LE, Parikh P, Roach MC, Michalski JM, Gach HM
Cureus. 2018 Mar 22; 10(3)e2359. doi: 10.7759/cureus.2359.

PMID:
    29805928
    [PubMed]
Related citations


Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Luh JY, Finkelstein SE, Michalski JM, Sandler H
Ann Intern Med. 2018 Apr 17; 168(8)607-608. doi: 10.7326/L17-0734.

PMID:
    29677258
    [PubMed - in process]
Related citations